Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Overexpression of corticotropin-releasing factor in intestinal mucosal eosinophils is associated with clinical severity in Diarrhea-Predominant Irritable Bowel Syndrome

  • Salvo-Romero, Eloísa
  • Martínez, Cristina|||0000-0002-9368-1356
  • Lobo Álvarez, Beatriz|||0000-0003-3391-7125
  • Rodiño-Janeiro, Bruno K.|||0000-0002-0633-6774
  • Pigrau Pastor, Marc|||0000-0001-6801-3017
  • Sánchez Chardi, Alejandro|||0000-0002-8789-1883
  • González Castro, Ana Maria|||0000-0003-3955-3318
  • Fortea, Marina|||0000-0001-8885-7495
  • Pardo-Camacho, Cristina
  • Nieto Ruiz, Adoración|||0000-0002-3421-2840
  • Expósito, Elba|||0000-0001-6088-3149
  • Guagnozzi, Danila|||0000-0002-6171-1901
  • Rodríguez-Urrutia, Amanda|||0000-0001-6882-205X
  • de Torres, Inés|||0000-0002-5495-9140
  • Farré, Ricard|||0000-0001-7158-171X
  • Azpiroz Vidaur, Fernando|||0000-0002-7327-960X
  • Alonso Cotoner, Carmen|||0000-0002-3483-2919
  • Santos, Javier|||0000-0002-4798-5033
  • Vicario Perez, Maria|||0000-0001-9622-3185
Corticotropin-releasing factor (CRF) has been identified in intestinal mucosal eosinophils and associated with psychological stress and gut dysfunction. Irritable bowel syndrome (IBS) is commonly characterized by altered intestinal motility, immune activation, and increased gut barrier permeability along with heightened susceptibility to psychosocial stress. Despite intensive research, the role of mucosal eosinophils in stress-associated gut dysfunction remains uncertain. In this study, we evaluated eosinophil activation profile and CRF content in the jejunal mucosa of diarrhea-predominant IBS (IBS-D) and healthy controls (HC) by gene/protein expression and transmission electron microscopy. We also explored the association between intestinal eosinophil CRF and chronic stress, and the potential mechanisms underlying the stress response by assessing eosinophil response to neuropeptides. We found that mucosal eosinophils displayed higher degranulation profile in IBS-D as compared to HC, with increased content of CRF in the cytoplasmic granules, which significantly correlated with IBS clinical severity, life stress background and depression. Eosinophils responded to substance P and carbachol by increasing secretory activity and CRF synthesis and release, without promoting pro-inflammatory activity, a profile similar to that found in mucosal eosinophils from IBS-D. Collectively, our results suggest that intestinal mucosal eosinophils are potential contributors to stress-mediated gut dysfunction through CRF production and release.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Mucosal Plasma Cell Activation and Proximity to Nerve Fibres Are Associated with Glycocalyx Reduction in Diarrhoea-Predominant Irritable Bowel Syndrome, Jejunal Barrier Alterations Underlying Clinical Manifestations

  • Pardo-Camacho, Cristina
  • Ganda Mall, John-Peter|||0000-0002-2120-7743
  • Martínez, Cristina|||0000-0002-9368-1356
  • Pigrau Pastor, Marc|||0000-0001-6801-3017
  • Expósito, Elba|||0000-0001-6088-3149
  • Albert-Bayo, Mercé|||0000-0002-9726-8083
  • Melón-Ardanaz, Elisa
  • Nieto Ruiz, Adoración|||0000-0002-3421-2840
  • Rodiño-Janeiro, Bruno
  • Fortea, Marina|||0000-0001-8885-7495
  • Guagnozzi, Danila|||0000-0002-6171-1901
  • Rodríguez-Urrutia, Amanda|||0000-0001-6882-205X
  • de Torres, Inés|||0000-0002-5495-9140
  • Santos-Briones, Ignacio
  • Azpiroz Vidaur, Fernando|||0000-0002-7327-960X
  • Lobo Álvarez, Beatriz|||0000-0003-3391-7125
  • Alonso Cotoner, Carmen|||0000-0002-3483-2919
  • Santos, Javier|||0000-0002-4798-5033
  • González Castro, Ana Maria|||0000-0003-3955-3318
  • Vicario Perez, Maria|||0000-0001-9622-3185
Irritable bowel syndrome (IBS) is a disorder of brain-gut interaction characterised by abdominal pain and changes in bowel habits. In the diarrhoea subtype (IBS-D), altered epithelial barrier and mucosal immune activation are associated with clinical manifestations. We aimed to further evaluate plasma cells and epithelial integrity to gain understanding of IBS-D pathophysiology. One mucosal jejunal biopsy and one stool sample were obtained from healthy controls and IBS-D patients. Gastrointestinal symptoms, stress, and depression scores were recorded. In the jejunal mucosa, RNAseq and gene set enrichment analyses were performed. A morphometric analysis by electron microscopy quantified plasma cell activation and proximity to enteric nerves and glycocalyx thickness. Immunoglobulins concentration was assessed in the stool. IBS-D patients showed differential expression of humoral pathways compared to controls. Activation and proximity of plasma cells to nerves and IgG concentration were also higher in IBS-D. Glycocalyx thickness was lower in IBS-D compared to controls, and this reduction correlated with plasma cell activation, proximity to nerves, and clinical symptoms. These results support humoral activity and loss of epithelial integrity as important contributors to gut dysfunction and clinical manifestations in IBS-D. Additional studies are needed to identify the triggers of these alterations to better define IBS-D pathophysiology.